000028 国药一致
已收盘 05-15 15:00:00
资讯
新帖
简况
每周股票复盘：国药一致（000028）Q1营收178.23亿净利降12.36%
证券之星 · 05-02
每周股票复盘：国药一致（000028）Q1营收178.23亿净利降12.36%
国药一致（000028）2026年一季报简析：净利润同比下降12.36%
证券之星 · 05-01
国药一致（000028）2026年一季报简析：净利润同比下降12.36%
国药一致（000028）披露董事、高级管理人员薪酬管理制度，4月29日股价上涨0.45%
证券之星 · 04-29
国药一致（000028）披露董事、高级管理人员薪酬管理制度，4月29日股价上涨0.45%
图解国药一致一季报：第一季度单季净利润同比下降12.36%
证券之星 · 04-29
图解国药一致一季报：第一季度单季净利润同比下降12.36%
每周股票复盘：国药一致（000028）Q1净利降12.36%
证券之星 · 04-26
每周股票复盘：国药一致（000028）Q1净利降12.36%
国药一致发布2026年第一季度业绩快报，盈利2.875亿元
证券之星 · 04-21
国药一致发布2026年第一季度业绩快报，盈利2.875亿元
每周股票复盘：国药一致（000028）2025年净利增76.80%
证券之星 · 04-19
每周股票复盘：国药一致（000028）2025年净利增76.80%
股市必读：国药一致（000028）4月16日董秘有最新回复
证券之星 · 04-17
股市必读：国药一致（000028）4月16日董秘有最新回复
国药一致：公司每年进行现金分红，注重回报广大股东
证券之星 · 04-16
国药一致：公司每年进行现金分红，注重回报广大股东
国药一致：4月10日召开业绩说明会，中信建投证券、招商证券等多家机构参与
证券之星 · 04-13
国药一致：4月10日召开业绩说明会，中信建投证券、招商证券等多家机构参与
股市必读：国药一致（000028）4月8日董秘有最新回复
证券之星 · 04-09
股市必读：国药一致（000028）4月8日董秘有最新回复
国药一致：2025年国大药房实现净利润0.60亿元
证券之星 · 04-08
国药一致：2025年国大药房实现净利润0.60亿元
国药一致：研发端推出医用耗材SPD智慧仓储解决方案
证券之星 · 04-08
国药一致：研发端推出医用耗材SPD智慧仓储解决方案
国药一致：差异系还要受到公司办理的其余列示于短期借款的供应链融资业务余额变动的影响
证券之星 · 04-08
国药一致：差异系还要受到公司办理的其余列示于短期借款的供应链融资业务余额变动的影响
国药一致（000028）披露2025年度业绩说明会公告，4月7日股价上涨0.91%
证券之星 · 04-07
国药一致（000028）披露2025年度业绩说明会公告，4月7日股价上涨0.91%
股市必读：国药一致（000028）4月3日董秘有最新回复
证券之星 · 04-07
股市必读：国药一致（000028）4月3日董秘有最新回复
每周股票复盘：国药一致（000028）2025年净利增76.8%
证券之星 · 04-05
每周股票复盘：国药一致（000028）2025年净利增76.8%
股市必读：国药一致年报 - 第四季度单季净利润同比增长142.27%
证券之星 · 04-03
股市必读：国药一致年报 - 第四季度单季净利润同比增长142.27%
国药一致（000028）披露2026年度审计机构续聘议案，4月2日股价上涨2.2%
证券之星 · 04-02
国药一致（000028）披露2026年度审计机构续聘议案，4月2日股价上涨2.2%
图解国药一致年报：第四季度单季净利润同比增长142.27%
证券之星 · 04-02
图解国药一致年报：第四季度单季净利润同比增长142.27%
暂无数据
公司概况
公司名称：
国药集团一致药业股份有限公司
所属行业：
批发业
上市日期：
1993-08-09
主营业务：
国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。
发行价格：
3.50
{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":24.14,"timestamp":1778828637000,"preClose":24.19,"halted":0,"volume":2156050,"delay":0,"changeRate":-0.0021,"floatShares":478000000,"shares":557000000,"eps":1.9682,"marketStatus":"已收盘","change":-0.05,"latestTime":"05-15 15:00:00","open":24.22,"high":24.31,"low":24.07,"amount":52126100,"amplitude":0.0099,"askPrice":24.15,"askSize":10,"bidPrice":24.14,"bidSize":85,"shortable":0,"etf":0,"ttmEps":1.9682,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":24.19,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":26.61,"lowLimit":21.77,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":556565077,"isCdr":false,"pbRate":0.71,"roa":"--","peRate":12.265014,"roe":"1.53%","epsLYR":2.04,"committee":0.202046,"marketValue":13435000000,"turnoverRate":0.0045,"status":1,"floatMarketCap":11540000000},"requestUrl":"/m/hq/s/000028/tweets","defaultTab":"tweets","newsList":[{"id":"2632647326","title":"每周股票复盘：国药一致（000028）Q1营收178.23亿净利降12.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647326","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632647326?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:10","pubTimestamp":1777666221,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，国药一致报收于24.54元，较上周的24.79元下跌1.01%。本周，国药一致4月29日盘中最高价报24.84元。本周关注点业绩披露要点：国药一致2026年一季报显示，一季度主营收入178.23亿元，同比下降2.57%；归母净利润2.87亿元，同比下降12.36%。公司公告汇总国药一致2026年第一季度实现营业收入17,823,409,770.31元，同比下降2.57%；归属于上市公司股东的净利润287,462,500.32元，同比下降12.36%；基本每股收益0.52元，同比下降11.86%；加权平均净资产收益率1.53%，同比下降0.31个百分点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660668","title":"国药一致（000028）2026年一季报简析：净利润同比下降12.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660668","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660668?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:34","pubTimestamp":1777588444,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期国药一致发布2026年一季报。根据财报显示，国药一致净利润同比下降12.36%。截至本报告期末，公司营业总收入178.23亿元，同比下降2.57%，归母净利润2.87亿元，同比下降12.36%。本次财报公布的各项数据指标表现不尽如人意。去年的净利率为1.54%，算上全部成本后，公司产品或服务的附加值不高。持有国药一致最多的基金为华夏国企改革混合，目前规模为1.38亿元，最新净值1.699，较上一交易日上涨2.16%，近一年上涨42.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100006378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631548767","title":"国药一致（000028）披露董事、高级管理人员薪酬管理制度，4月29日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631548767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631548767?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:17","pubTimestamp":1777472263,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，国药一致报收于24.8元，较前一交易日上涨0.45%，最新总市值为138.03亿元。该股当日开盘24.63元，最高24.84元，最低24.62元，成交额达9965.01万元，换手率为0.84%。近日，国药集团一致药业股份有限公司披露《董事、高级管理人员薪酬管理制度》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900068815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","000028","BK0196","BK0010","BK0188","BK0175","BK0250","BK0082","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631182405","title":"图解国药一致一季报：第一季度单季净利润同比下降12.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631182405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631182405?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:15","pubTimestamp":1777461348,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致2026年一季报显示，一季度公司主营收入178.23亿元，同比下降2.57%；归母净利润2.87亿元，同比下降12.36%；扣非净利润2.8亿元，同比下降11.77%；负债率55.39%，投资收益5798.3万元，财务费用3430.91万元，毛利率9.96%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900059782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630024348","title":"每周股票复盘：国药一致（000028）Q1净利降12.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630024348","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630024348?lang=zh_cn&edition=full","pubTime":"2026-04-26 05:20","pubTimestamp":1777152023,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，国药一致报收于24.79元，较上周的26.05元下跌4.84%。本周，国药一致4月20日盘中最高价报26.24元。公司公告汇总国药集团一致药业股份有限公司发布2026年第一季度业绩快报，营业总收入178.23亿元，同比下降2.57%；营业利润3.77亿元，同比下降14.24%；归属于上市公司股东的净利润2.87亿元，同比下降12.36%。分销板块收入133.56亿元，同比下降1.72%，净利润1.99亿元，同比下降13.60%，主要受行业政策变化、竞争加剧及应收账款账龄延长导致坏账准备增加影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0082","BK0175","BK0196","BK0188","BK0185","BK0010","BK0028","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629082357","title":"国药一致发布2026年第一季度业绩快报，盈利2.875亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629082357","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629082357?lang=zh_cn&edition=full","pubTime":"2026-04-21 17:40","pubTimestamp":1776764435,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致近日即将发布2026年一季报，根据4月21日发布的业绩快报，归属净利润盈利2.875亿元，同比减少12.36%。零售板块实现营业收入47.39亿元，同比下降4.89%；净利润0.05亿元，同比增长15.42%。受流感季变化、市场竞争等因素影响，国大药房销售收入有所下降，但降幅持续收窄。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100040042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","BK0250","BK0185","BK0188","BK0010","BK0175","000028","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628759368","title":"每周股票复盘：国药一致（000028）2025年净利增76.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628759368","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628759368?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:23","pubTimestamp":1776536587,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，国药一致报收于26.05元，较上周的26.24元下跌0.72%。本周，国药一致4月16日盘中最高价报26.79元。本周关注点来自业绩披露要点：2025年归母净利润11.36亿元，同比增长76.80%。来自机构调研要点：国大药房2025年自有品牌销售额约20亿元，零售常规占比提升至15%左右。2025年下半年以来，零售同店表现逐步向好，呈现增长趋势。2025年销售规模超8000万元，同比翻倍增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0196","BK0082","BK0010","BK0028","000028","BK0188","BK0175","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628400248","title":"股市必读：国药一致（000028）4月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2628400248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628400248?lang=zh_cn&edition=full","pubTime":"2026-04-17 01:59","pubTimestamp":1776362350,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，国药一致报收于26.51元，上涨0.23%，换手率1.37%，成交量6.56万手，成交额1.74亿元。董秘最新回复投资者： 公司业绩在持续增长且优秀，140亿市值仍持续锐减，破发破净非常严重，公司实际控制人及全体管理层能否重视全体股东的利益？二级市场股价受多种因素影响。当日关注点来自交易信息汇总：4月16日主力资金净流出1178.55万元，散户资金净流入1792.24万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700003034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0250","BK0082","BK0188","000028","BK0185","BK0175","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627260153","title":"国药一致：公司每年进行现金分红，注重回报广大股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2627260153","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627260153?lang=zh_cn&edition=full","pubTime":"2026-04-16 15:57","pubTimestamp":1776326225,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问：以其巨额分红，不如巨额回购注消股份，建议公司回购。国药一致回复：感谢您的关注！公司每年进行现金分红，注重回报广大股东，也会结合相关法规要求和公司实际条件研究探讨其他利润分配方式。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600026544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0175","BK0010","BK0196","BK0082","BK0188","000028","BK0250","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627255485","title":"国药一致：4月10日召开业绩说明会，中信建投证券、招商证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2627255485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627255485?lang=zh_cn&edition=full","pubTime":"2026-04-13 11:30","pubTimestamp":1776051028,"startTime":"0","endTime":"0","summary":"具体内容如下： 一、介绍经营情况及市值提升计划执行情况 1、2025年度经营情况 详见公司于2026年4月2日披露的国药一致2025年年度报告。我们正在制定“十五五规划”，未来将与市场进行沟通介绍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300010282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1564","BK0188","BK0185","BK0196","BK0010","600999","06066","BK0250","BK0175","BK0082","06099","BK0028","BK0276","BK1147","000028","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626926101","title":"股市必读：国药一致（000028）4月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2626926101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626926101?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:19","pubTimestamp":1775668751,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘，国药一致报收于26.47元，下跌0.64%，换手率1.56%，成交量7.44万手，成交额1.97亿元。受外部环境因素影响，医药零售行业面临较大挑战。国大药房持续通过聚焦核心品项目、亏损店治理、强化成本控制等举措提升利润率。2025年，剔除商誉和无形资产减值的影响后，国大药房实现净利润0.60亿元，同比增长139.28%。当日关注点来自交易信息汇总：4月8日主力资金净流入584.4万元，游资积极介入，散户资金呈净流出态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900001084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0082","000028","BK0250","BK0175","BK0185","BK0196","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625913915","title":"国药一致：2025年国大药房实现净利润0.60亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2625913915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625913915?lang=zh_cn&edition=full","pubTime":"2026-04-08 15:18","pubTimestamp":1775632692,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致04月08日在投资者关系平台上答复投资者关心的问题。受外部环境因素影响，医药零售行业面临较大挑战。国大药房持续通过聚焦核心品项目、亏损店治理、强化成本控制等举措提升利润率。2025年，剔除商誉和无形资产减值的影响后，国大药房实现净利润0.60亿元，同比增长139.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800017904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625941913","title":"国药一致：研发端推出医用耗材SPD智慧仓储解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2625941913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625941913?lang=zh_cn&edition=full","pubTime":"2026-04-08 15:18","pubTimestamp":1775632691,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)04月08日在投资者关系平台上答复投资者关心的问题。投资者提问：人工智能飞速发展，公司在这方面有何布局？国药一致回复：感谢您的关注！公司根据业务发展需求，积极引入先进生产力要素，实现降本增效。研发端推出医用耗材SPD智慧仓储解决方案，推进医疗设备全生命周期运营管理软件研发，强化产品竞争力；运营端落地RPA自动处理订单、OCR识别首营数据、AGV优化仓储配送，同时以智能系统赋能风控、营销、供应链管理，推动业务高质量发展。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800017903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0028","BK0196","BK0010","BK0185","000028","BK0250","BK0188","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625913910","title":"国药一致：差异系还要受到公司办理的其余列示于短期借款的供应链融资业务余额变动的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2625913910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625913910?lang=zh_cn&edition=full","pubTime":"2026-04-08 15:18","pubTimestamp":1775632689,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致04月08日在投资者关系平台上答复投资者关心的问题。差异系还要受到公司办理的其余列示于短期借款的供应链融资业务余额变动的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800017901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0188","BK0175","BK0028","000028","BK0082","BK0196","BK0250","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625939250","title":"国药一致（000028）披露2025年度业绩说明会公告，4月7日股价上涨0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625939250","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625939250?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:53","pubTimestamp":1775555593,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，国药一致报收于26.64元，较前一交易日上涨0.91%，最新总市值为148.27亿元。该股当日开盘26.26元，最高26.8元，最低25.91元，成交额达1.8亿元，换手率为1.43%。近日，国药集团一致药业股份有限公司披露《关于举办2025年度业绩说明会的公告》。公告显示，公司将于2026年4月10日15:30-16:30通过网络及电话会议方式，在“价值在线”平台举办2025年度业绩说明会，就公司经营业绩、发展战略等与投资者进行交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0010","BK0185","BK0188","BK0028","BK0196","000028","BK0175","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625860579","title":"股市必读：国药一致（000028）4月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625860579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625860579?lang=zh_cn&edition=full","pubTime":"2026-04-07 02:46","pubTimestamp":1775501173,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，国药一致报收于26.4元，下跌2.22%，换手率1.6%，成交量7.63万手，成交额2.02亿元。关于应收账款问题，受外部环境因素影响，医药分销行业应收账款周期出现普遍性延长，截至2025年末公司应收账款也有所增加。来自公司公告汇总：国药一致将于2026年4月10日举办2025年度业绩说明会，投资者可提前提交问题并线上参与。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700001093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","BK0250","BK0185","BK0188","BK0010","BK0175","000028","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625619323","title":"每周股票复盘：国药一致（000028）2025年净利增76.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625619323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625619323?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:49","pubTimestamp":1775328548,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，国药一致报收于26.4元，较上周的25.7元上涨2.72%。本周，国药一致4月2日盘中最高价报27.19元。本周关注点来自业绩披露要点：国药一致2025年归母净利润11.36亿元，同比增长76.8%。公司公告汇总国药一致2025年年度报告摘要显示，2025年末总资产490.96亿元，净资产186.10亿元。预计分配现金股利3.43亿元，占归母净利润的30.18%，送股后总股本将增至612,221,584股。扬州国大2025年末净资产5,499.57万元，净利润354.10万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0196","BK0082","BK0010","BK0028","000028","BK0188","BK0175","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624689324","title":"股市必读：国药一致年报 - 第四季度单季净利润同比增长142.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624689324","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624689324?lang=zh_cn&edition=full","pubTime":"2026-04-03 01:53","pubTimestamp":1775152390,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘，国药一致报收于27.0元，上涨2.2%，换手率3.48%，成交量16.63万手，成交额4.47亿元。经营活动产生的现金流量净额为1,638,588,925.27元，同比下降49.91%。预计分配现金股利342,844,087.43元，占本年度归属于公司股东净利润的30.18%。送股后总股本将增至612,221,584股。公司对国药集团财务有限公司进行风险持续评估，截至2025年12月31日，其资产规模为464.53亿元，营业收入7.53亿元，资本充足率为18.32%，流动性比例为73.29%，内部控制制度健全，风险管理未发现重大缺陷。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300001606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624500665","title":"国药一致（000028）披露2026年度审计机构续聘议案，4月2日股价上涨2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624500665","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624500665?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:49","pubTimestamp":1775141350,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘，国药一致报收于27.0元，较前一交易日上涨2.2%，最新总市值为150.27亿元。公司于近日披露《关于续聘公司2026年度财务报告审计机构和内部控制审计机构的公告》。公告显示，国药集团一致药业股份有限公司于2026年3月31日召开第十届董事会第七次会议，审议通过续聘天健会计师事务所为公司2026年度财务报告审计机构和内部控制审计机构的议案。本次续聘尚需提交公司股东会审议，自股东会决议通过之日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200042868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0188","BK0175","BK0028","000028","BK0082","BK0196","BK0250","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624543715","title":"图解国药一致年报：第四季度单季净利润同比增长142.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624543715","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624543715?lang=zh_cn&edition=full","pubTime":"2026-04-02 01:34","pubTimestamp":1775064874,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致2025年年报显示，当年度公司主营收入734.16亿元，同比下降1.29%；归母净利润11.36亿元，同比上升76.8%；扣非净利润10.96亿元，同比上升88.53%；其中2025年第四季度，公司单季度主营收入182.91亿元，同比上升2.12%；单季度归母净利润1.79亿元，同比上升142.27%；单季度扣非净利润1.73亿元，同比上升138.98%；负债率55.95%，投资收益2.18亿元，财务费用1.83亿元，毛利率10.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200000754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778860132695,"stockEarnings":[{"period":"1week","weight":-0.0135},{"period":"1month","weight":-0.0551},{"period":"3month","weight":-0.0617},{"period":"6month","weight":-0.0742},{"period":"1year","weight":-0.0227},{"period":"ytd","weight":-0.0151}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0376},{"period":"3month","weight":0.0235},{"period":"6month","weight":0.047},{"period":"1year","weight":0.2274},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"0人","perCapita":"--","listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","registeredCapital":"55656万元","survey":" 国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}